J1738 HCPCS Level II code: Injection, meloxicam, 1 mg
J1738 is the HCPCS code for “Injection, meloxicam, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1738Injection, meloxicam, 1 mg
Short description: Inj. meloxicam 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J1738 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Oct 1, 2020
Where J1738 sits
- 1J codesDrugs administered other than orally
- 2Active code J1738Injection, meloxicam, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1738 mean?
J1738 is the HCPCS code for “Injection, meloxicam, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1738?
CMS lists J1738’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1738
All J codesJ1725Injection, hydroxyprogesterone caproate, 1 mgJ1726Injection, hydroxyprogesterone caproate, (makena), 10 mgJ1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgJ1730Injection, diazoxide, up to 300 mgJ1736Injection, meloxicam (delova), 1 mgJ1737Injection, meloxicam (azurity), 1 mgJ1740Injection, ibandronate sodium, 1 mgJ1741Injection, ibuprofen, 100 mgJ1742Injection, ibutilide fumarate, 1 mgJ1743Injection, idursulfase, 1 mgJ1744Injection, icatibant, 1 mgJ1745Injection, infliximab, excludes biosimilar, 10 mg